Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published online Nov. 16 in Circulation.
Dec 4, 2023
0
16
(HealthDay)—Readmission after sepsis hospitalization is common and is associated with considerable costs, according to a study published in the March issue of CHEST.
Mar 4, 2019
0
133
A study supported by the National Institutes of Health found that people who experienced acute kidney injury (AKI) during a hospitalization, including those admitted with AKI or who developed AKI in the hospital, were more ...
Apr 27, 2023
0
11
Numerous studies have shown that spirituality can help improve quality of life for people with chronic diseases like cancer. According to a literature review published today in JACC Heart Failure, spirituality can also have ...
Mar 28, 2022
0
54
Heart failure remains the leading cause of mortality in the U.S. During a heart attack blood stops flowing into the heart. Without oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead, it replaces ...
Feb 13, 2024
0
1
Chronic heart failure (CHF) patients with predominant central sleep apnea (CSA) are at higher risk for death and unplanned hospitalization than those who have both CSA and obstructive sleep apnea (OSA), whether or not they ...
May 18, 2016
0
8
For older adults, being physically active is an important part of overall good health. In fact, experts say that nine percent of all premature deaths are caused by not getting enough physical activity. Physical activity is ...
Nov 1, 2019
0
4
(HealthDay) -- Menthol cigarettes may pose an even greater risk for stroke than other types of cigarettes, especially for women and non-black smokers, says a new, large study.
Apr 9, 2012
0
0
The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking ...
Nov 17, 2020
0
4
SGLT-2 inhibitors, a type of diabetes medicine, decreased cardiovascular risk among adults with chronic kidney disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions ...
Nov 7, 2022
0
16
